Invesco Biotechnology & Genome ETF Rating $70.52 -0.51 (-0.72%) As of 09/19/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Invesco Biotechnology & Genome ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PBE Aggregate RatingModerate Buy 2.72Holdings in PBE have an aggregate rating of Moderate Buy based on 371 analyst ratings issued in the past year covering 25 companies (91.9% of the portfolio).PBE Aggregate Price Target$70.52High Prediction$70.52Average Prediction$70.52Low Prediction$70.52Holdings in PBE have an aggregate price target of $70.52 and a range of $70.52 to $70.52 covering 25 companies (91.9% of the portfolio).PBE Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy6 Buy rating(s)Moderate Buy14 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Biotechnology & Genome ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 PBE Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings7.05%ALNYAlnylam Pharmaceuticals$453.56+0.3%3.886 of 5 stars2.86$439.58 -3.1%28Trending NewsAnalyst Forecast5.89%UTHRUnited Therapeutics$417.57+1.9%4.6689 of 5 stars2.69$438.85 5.1%13Trending NewsInsider TradeHigh Trading Volume5.43%ILMNIllumina$102.75-0.3%4.742 of 5 stars2.21$123.06 19.8%19Positive NewsHigh Trading Volume5.07%RPRXRoyalty Pharma$36.24+1.4%4.8684 of 5 stars3.33$48.00 32.5%3Positive NewsHigh Trading Volume4.73%GILDGilead Sciences$114.09+0.4%4.9211 of 5 stars2.89$117.17 2.7%28Positive NewsAnalyst ForecastInsider TradeHigh Trading Volume4.70%AMGNAmgen$285.41+3.5%4.5621 of 5 stars2.24$304.43 6.7%21Positive NewsHigh Trading Volume4.66%BMRNBioMarin Pharmaceutical$54.36-1.4%4.962 of 5 stars2.64$92.60 70.3%22Positive NewsShort Interest ↑High Trading Volume4.17%ARWRArrowhead Pharmaceuticals$30.69-2.6%4.2177 of 5 stars3.00$43.14 40.6%8Insider TradeAnalyst Revision4.12%VRTXVertex Pharmaceuticals$383.12-1.0%4.905 of 5 stars2.57$496.05 29.5%28Positive NewsHigh Trading Volume3.41%MNKDMannKind$5.43-3.2%4.2902 of 5 stars3.17$11.17 105.6%6Analyst ForecastInsider TradeShort Interest ↓3.37%HALOHalozyme Therapeutics$77.81+1.5%4.5818 of 5 stars2.33$67.11 -13.8%12Positive NewsHigh Trading Volume3.32%COLLCollegium Pharmaceutical$35.75-1.1%3.7321 of 5 stars3.00$42.33 18.4%33.29%INCYIncyte$86.53+0.6%4.7756 of 5 stars2.33$82.53 -4.6%18Trending NewsAnalyst ForecastShort Interest ↓High Trading Volume3.21%AVXLAnavex Life Sciences$8.46-2.4%3.8003 of 5 stars3.00$44.00 420.1%23.17%PTGXProtagonist Therapeutics$62.20+0.1%1.8573 of 5 stars3.08$68.08 9.5%12Analyst ForecastHigh Trading Volume3.15%FOLDAmicus Therapeutics$8.33-1.8%4.0551 of 5 stars2.89$15.78 89.4%9News CoverageAnalyst UpgradeHigh Trading Volume2.89%NBIXNeurocrine Biosciences$145.23-0.3%4.4919 of 5 stars2.85$160.26 10.4%20Positive NewsHigh Trading Volume2.89%ACADACADIA Pharmaceuticals$24.42-1.3%4.1484 of 5 stars2.65$29.65 21.4%202.74%PTCTPTC Therapeutics$60.48-3.8%3.8845 of 5 stars2.53$69.00 14.1%15Insider Trade2.69%VCYTVeracyte$34.11+2.6%3.6155 of 5 stars2.70$40.90 19.9%10Positive NewsHigh Trading Volume2.67%QGENQiagen$45.98+0.5%4.4396 of 5 stars2.27$49.69 8.1%11Positive News2.53%DVAXDynavax Technologies$9.69-0.6%4.3164 of 5 stars2.50$24.33 151.1%4Positive NewsHigh Trading Volume2.46%RGENRepligen$122.30-1.7%4.8348 of 5 stars2.67$166.67 36.3%122.16%EXELExelixis$40.10-0.9%4.6666 of 5 stars2.61$44.42 10.8%23Positive NewsAnalyst UpgradeHigh Trading Volume2.12%EXASExact Sciences$53.32-0.5%4.8216 of 5 stars2.88$68.05 27.6%24Short Interest ↓ This page (NYSEARCA:PBE) was last updated on 9/20/2025 by MarketBeat.com Staff From Our PartnersCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredElon’s Out 🚫. Trump’s DOGE Payouts Keep Flowing (Up to $32K a Year)DOGE payouts are already moving. Every 90 days, billions flow out — whether you’ve claimed your share or not. ...Angel Publishing | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredWhy silver could go 100X higherInflation is destroying purchasing power at 10–14% per year. Gold will protect you — but not the way you think...Golden Portfolio | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Biotechnology & Genome ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Biotechnology & Genome ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
